Abstract
The inherent or acquired resistance to paclitaxel and cisplatin, which are commonly used chemotherapeutic agents for ovarian cancer treatment, remains an important issue in chemotherapy of multidrug resistant ovarian cancer. Currently, it is still challenging to deal with the recurrent or advanced stage ovarian cancer. When drug efflux and anti-apoptotic pathways are highly interdependent and also involved in developing the resistance of multidrug resistant ovarian cancer, simultaneous inhibition of both pathways represents the potential targets to enhance the efficacy of chemotherapy. Here, we introduce PLGA nanoparticles system as a "dual RNAi delivery system" to contain both MDR1 and BCL2 siRNA, which is designed for simultaneous inhibition of drug efflux and cell death defense pathways. In the present studies, siRNA-loaded PLGA nanoparticles efficiently elicit the simultaneous suppression of both genes, which consequently shows more enhanced drug-sensitivity than sole suppression of drug efflux or anti-apoptosis in the resistant ovarian cancer cells, owing to the interdependence of both pathways. Our siRNA-loaded PLGA nanoparticles for co-delivering MDR1 and BCL2 siRNA provide an efficient combination therapy strategy to ov...Continue Reading
References
Jun 6, 2000·Advanced Drug Delivery Reviews·H Okada
Aug 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jayanth PanyamVinod Labhasetwar
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
Jun 26, 2003·Journal of Experimental Therapeutics & Oncology·Daniel E Lopes de MenezesLawrence D Mayer
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Aug 6, 2003·Gene Therapy·I PerlsteinR J Levy
Aug 21, 2003·International Journal of Pharmaceutics·Jayanth PanyamVinod Labhasetwar
Sep 7, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Sun Hwa KimTae Gwan Park
Oct 28, 2005·Journal of Neural Transmission·U SchmittS Härtter
Aug 22, 2006·Current Gene Therapy·Maite VerreaultMarcel B Bally
Mar 5, 2008·Biotechnology Letters·So-Jung Gwak, Byung-Soo Kim
May 22, 2009·Nature Materials·Michael J Campolongo, Dan Luo
Oct 6, 2009·Biomaterials·Yogesh B PatilJayanth Panyam
Oct 20, 2009·International Journal of Pharmaceutics·Dongmei CunHanne Mørck Nielsen
Jun 22, 2010·Cancer Chemotherapy and Pharmacology·Yaprak DönmezUfuk Gündüz
Oct 23, 2010·Advanced Drug Delivery Reviews·Sarbari Acharya, Sanjeeb K Sahoo
Sep 10, 2011·Biomaterials·Feihu WangYue Liu
Oct 12, 2011·ACS Nano·Kyung-mi ChoiHyung Jun Ahn
Dec 16, 2011·Immunological Reviews·Iris K Pang, Akiko Iwasaki
May 24, 2014·Biomaterials·Kyung-mi ChoiHyung Jun Ahn
Citations
Aug 15, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Christian SecaCiro Isidoro
Oct 28, 2019·Pharmaceutics·Rossella FarraGabriele Grassi
May 9, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Muhammad Asim FarooqBo Wang
Jun 13, 2020·Frontiers in Cell and Developmental Biology·Zied BoudhraaAnne-Marie Mes-Masson
Dec 19, 2018·Pharmaceutical Research·Ankur SharmaMohamed El-Tanani
May 31, 2020·Molecular Cancer Research : MCR·Luca X ZampieriPierre Sonveaux
Jan 5, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Bruna G CarvalhoLucimara G de la Torre
Oct 22, 2020·International Journal of Pharmaceutics·Imran TariqUdo Bakowsky
Oct 24, 2020·ACS Combinatorial Science·Milad AshrafizadehPooyan Makvandi
Mar 9, 2021·Wiley Interdisciplinary Reviews. RNA·Mingyuan ZouJian Xu
May 7, 2020·Asian Journal of Pharmaceutical Sciences·Yi PengLushan Yu
Apr 1, 2021·Life Sciences·Sepideh MirzaeiHaroon Khan
Mar 29, 2021·Biochemical and Biophysical Research Communications·Theeraphong Pho-IamChatchawan Srisawat
Apr 29, 2021·OncoTargets and Therapy·Yuwen HanYanli Zheng
Nov 8, 2020·Life Sciences·Santoshi NaikSrinivas Mutalik
Jul 3, 2021·Cancers·Amal A Al-DossaryAbdulaziz M Almalik
Oct 28, 2019·Molecular Pharmaceutics·Seo Young KwakHyung Jun Ahn
Aug 20, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Naseer MaliyakkalNayanabhirama Udupa
Apr 7, 2020·Nano Letters·Qingfei ZhangYubin Huang
Aug 27, 2021·The Journal of Physical Chemistry. B·Sudipta SenapatiPralay Maiti
Dec 12, 2020·Acta Pharmaceutica Sinica. B·Nitin Bharat CharbeFlavia C Zacconi
Sep 28, 2020·International Journal of Pharmaceutics·Ujjwal JoshiVladimir Torchilin